TRAXXSSON
Traxxsson is a biotechnology company that develops diagnostics for cancer using protein biomarkers. It uses a proprietary panel of biomarkers to identify at-risk patients who have questionable radiology images. It has three tests: PRO CancSure to identify prostate cancer patients in need of aggressive treatment, BRE CancSure to confirm the presence of breast cancer in women with positive mammograms, and LNG CancSure to confirm the presence of lung cancer in patients with positive low-density CAT scan results. The company was founded in 2009 and is based in St. Louis, Missouri.
TRAXXSSON
Industry:
Biotechnology Health Diagnostics Life Science Medical
Founded:
2009-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Status:
Active
Total Funding:
350 K USD
Similar Organizations
Chesapeake PERL
Chesapeake PERL is a biotechnology company that develops and produces proteins such as humanized glycoproteins and therapeutics.
Liquid Biotech
Liquid Biotech is a technology for cancer diagnostics and gene discover
MAVIDx
MAVIDx is a biotechnology company that develops a diagnostic platform for infectious disease testing services.
Current Employees Featured
Founder
Investors List
Missouri Technology Corporation
Missouri Technology Corporation investment in Seed Round - Traxxsson
St. Louis Arch Angels
St. Louis Arch Angels investment in Seed Round - Traxxsson